Clinical Effectiveness of Quetiapine in Children and Adolescents with Tourette's Syndrome

Mazlum Copur1; Baki Arpaci2; Turkay Demir1; Halis Narin3


Clin Drug Invest. 2007;27(2):123-130. 

In This Article


Our results suggest that the atypical antipsychotic quetiapine is effective in children and adolescents with Tourette's syndrome for reducing tic severity, has a good safety profile and is well tolerated except for causing mild weight gain. However, we suggest that prospective double-blind controlled studies are required to further evaluate the effectiveness of quetiapine in the treatment of Tourette's syndrome.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: